STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization
暂无分享,去创建一个
A. Yoshimura | Y. Sekine | T. Matsuda | K. Oritani | Akihiko Yoshimura | Tadashi Matsuda | R. Muromoto | S. Togi | Ryuta Muromoto | Yuichi Kitai | Masashi Iwakami | Kodai Saitoh | Sumihito Togi | Serina Isayama | Yuichi Sekine | Jun-Ichi Kashiwakura | Kenji Oritani | Yuichi Kitai | J. Kashiwakura | Kodai Saitoh | Masashi Iwakami | Serina Isayama
[1] A. Sorkin,et al. Endocytosis and signalling: intertwining molecular networks , 2009, Nature Reviews Molecular Cell Biology.
[2] A. Yoshimura,et al. Signal-Transducing Adaptor Protein-2 Regulates Integrin-Mediated T Cell Adhesion through Protein Degradation of Focal Adhesion Kinase1 , 2007, The Journal of Immunology.
[3] Y. Huang,et al. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells , 2010, Oncogene.
[4] A. Yoshimura,et al. STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis , 2018 .
[5] C. Korch,et al. Molecular characterization of human prostate carcinoma cell lines , 2003, The Prostate.
[6] S. Akira,et al. Negative Regulation of Melanoma Differentiation-associated Gene 5 (MDA5)-dependent Antiviral Innate Immune Responses by Arf-like Protein 5B* , 2014, The Journal of Biological Chemistry.
[7] J. Menéndez,et al. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands. , 2012, International journal of oncology.
[8] A. Gemma,et al. F1000 highlights , 2010 .
[9] A. Yoshimura,et al. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation. , 2009, Biochemical and biophysical research communications.
[10] A. Yoshimura,et al. Involvement of STAP‐2 in Brk‐mediated phosphorylation and activation of STAT5 in breast cancer cells , 2011, Cancer science.
[11] Y. Yarden,et al. Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases , 2004, Oncogene.
[12] Antony W Burgess,et al. Epidermal growth factor receptor: mechanisms of activation and signalling. , 2003, Experimental cell research.
[13] Z. Kam,et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.
[14] A. Yoshimura,et al. Physical and Functional Interactions between STAP-2/BKS and STAT5* , 2005, Journal of Biological Chemistry.
[15] A. Yoshimura,et al. STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body* , 2015, The Journal of Biological Chemistry.
[16] A. Yoshimura,et al. Signal-Transducing Adaptor Protein-2 Controls the IgE-Mediated, Mast Cell–Mediated Anaphylactic Responses , 2014, The Journal of Immunology.
[17] I. Mellinghoff,et al. Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts. , 2002, Cancer research.
[18] M. Rubin,et al. A phase II trial of gefitinib in patients with non‐metastatic hormone‐refractory prostate cancer , 2007, BJU international.
[19] I. Madshus,et al. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation. , 2004, Experimental cell research.
[20] G. Mills,et al. Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR , 2011, Oncogene.
[21] S. Minoguchi,et al. STAP-2/BKS, an Adaptor/Docking Protein, Modulates STAT3 Activation in Acute-phase Response through Its YXXQ Motif* , 2003, The Journal of Biological Chemistry.
[22] Y. Sekine,et al. Signal transducer and activator of transcription 3 regulation by novel binding partners. , 2015, World journal of biological chemistry.
[23] A. Yoshimura,et al. Interactions of STAP-2 with Brk and STAT3 Participate in Cell Growth of Human Breast Cancer Cells* , 2010, The Journal of Biological Chemistry.
[24] A. Yoshimura,et al. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl. , 2009, Biochemical and biophysical research communications.
[25] E. Nishida,et al. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway , 2002, Nature Cell Biology.
[26] L. Seymour,et al. Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] J. Brugge,et al. Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers , 1999, Molecular and Cellular Biology.
[28] S. Akira,et al. Modulation of TLR4 Signaling by a Novel Adaptor Protein Signal-Transducing Adaptor Protein-2 in Macrophages1 , 2006, The Journal of Immunology.
[29] K. Herrup,et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.
[30] H. Sakurai,et al. TAK1-Mediated Serine/Threonine Phosphorylation of Epidermal Growth Factor Receptor via p38/Extracellular Signal-Regulated Kinase: NF-κB-Independent Survival Pathways in Tumor Necrosis Factor Alpha Signaling , 2009, Molecular and Cellular Biology.